These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 9125579)
1. Characterization of the physiological requirements for the bactericidal effects of a monoclonal antibody to OspB of Borrelia burgdorferi by confocal microscopy. Escudero R; Halluska ML; Backenson PB; Coleman JL; Benach JL Infect Immun; 1997 May; 65(5):1908-15. PubMed ID: 9125579 [TBL] [Abstract][Full Text] [Related]
2. Functional heterogeneity in the antibodies produced to Borrelia burgdorferi. Benach JL Wien Klin Wochenschr; 1999 Dec; 111(22-23):985-9. PubMed ID: 10666815 [TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody to OspA inhibits association of Borrelia burgdorferi with human endothelial cells. Comstock LE; Fikrig E; Shoberg RJ; Flavell RA; Thomas DD Infect Immun; 1993 Feb; 61(2):423-31. PubMed ID: 7678585 [TBL] [Abstract][Full Text] [Related]
4. A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein. Sadziene A; Jonsson M; Bergström S; Bright RK; Kennedy RC; Barbour AG Infect Immun; 1994 May; 62(5):2037-45. PubMed ID: 7513309 [TBL] [Abstract][Full Text] [Related]
5. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey. Aydintug MK; Gu Y; Philipp MT Infect Immun; 1994 Nov; 62(11):4929-37. PubMed ID: 7927774 [TBL] [Abstract][Full Text] [Related]
6. Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins. Bunikis J; Barbour AG Infect Immun; 1999 Jun; 67(6):2874-83. PubMed ID: 10338494 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies with in vitro borreliacidal activities define the outer surface proteins A and B of Borrelia burgdorferi. Moskophidis M; Luther B Zentralbl Bakteriol; 1993 Jun; 279(2):201-13. PubMed ID: 8219491 [TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi. Ma J; Gingrich-Baker C; Franchi PM; Bulger P; Coughlin RT Infect Immun; 1995 Jun; 63(6):2221-7. PubMed ID: 7539408 [TBL] [Abstract][Full Text] [Related]
9. A bactericidal monoclonal antibody elicits a change in its antigen, OspB of Borrelia burgdorferi, that can be detected by limited proteolysis. Katona LI; Ayalew S; Coleman JL; Benach JL J Immunol; 2000 Feb; 164(3):1425-31. PubMed ID: 10640758 [TBL] [Abstract][Full Text] [Related]
10. Crystallization and preliminary X-ray analysis of Borrelia burgdorferi outer surface protein A (OspA) complexed with a murine monoclonal antibody Fab fragment. Li H; Lawson CL J Struct Biol; 1995; 115(3):335-7. PubMed ID: 8573475 [TBL] [Abstract][Full Text] [Related]
12. Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB. Coleman JL; Rogers RC; Benach JL Infect Immun; 1992 Aug; 60(8):3098-104. PubMed ID: 1639477 [TBL] [Abstract][Full Text] [Related]
13. Structural investigation of Borrelia burgdorferi OspB, a bactericidal Fab target. Becker M; Bunikis J; Lade BD; Dunn JJ; Barbour AG; Lawson CL J Biol Chem; 2005 Apr; 280(17):17363-70. PubMed ID: 15713683 [TBL] [Abstract][Full Text] [Related]
14. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi. Ma J; Bulger PA; Davis DR; Perilli-Palmer B; Bedore DA; Kensil CR; Young EM; Hung CH; Seals JR; Pavia CS Vaccine; 1994 Aug; 12(10):925-32. PubMed ID: 7975834 [TBL] [Abstract][Full Text] [Related]
15. Presence of common antigenic epitope in outer surface protein (Osp) A and OspB of Japanese isolates identified as Borrelia garinii. Masuzawa T; Kaneda K; Suzuki H; Wang J; Yamada K; Kawabata H; Johnson RC; Yanagihara Y Microbiol Immunol; 1996; 40(6):455-8. PubMed ID: 8839432 [TBL] [Abstract][Full Text] [Related]
16. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms. Roehrig JT; Piesman J; Hunt AR; Keen MG; Happ CM; Johnson BJ J Immunol; 1992 Dec; 149(11):3648-53. PubMed ID: 1431134 [TBL] [Abstract][Full Text] [Related]
17. Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes. Ma J; Bulger PA; Dante S; Davis DR; Perilli-Palmer B; Coughlin RT J Infect Dis; 1995 Apr; 171(4):909-15. PubMed ID: 7706819 [TBL] [Abstract][Full Text] [Related]
18. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA. Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781 [TBL] [Abstract][Full Text] [Related]
19. Identification of a highly cross-reactive outer surface protein B epitope among diverse geographic isolates of Borrelia spp. causing Lyme disease. Shoberg RJ; Jonsson M; Sadziene A; Bergström S; Thomas DD J Clin Microbiol; 1994 Feb; 32(2):489-500. PubMed ID: 7512097 [TBL] [Abstract][Full Text] [Related]
20. Borrelia burgdorferi escape mutants that survive in the presence of antiserum to the OspA vaccine are killed when complement is also present. Solé M; Bantar C; Indest K; Gu Y; Ramamoorthy R; Coughlin R; Philipp MT Infect Immun; 1998 Jun; 66(6):2540-6. PubMed ID: 9596714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]